“…The loss of the BglII cleavage site between the BglII K (genomic residues 14588 to 25147, 10,560 bp, strain 17) and Q/#13 (genomic residues 25148 to 25378, 231 bp, strain 17) fragments (8,21) indicates a mutation at or adjacent to residues 25147 to 25148 in the coding region of the U L 12 gene (genomic residues 25007 to 26887, strain 17, DNase/alkaline nuclease) (26,31), as summarized in Table 2. The loss of the SalI cleavage sites between the SalI C and J fragments and between the SalI F and J fragments, resulting in SaCFJ M (8,21), indicates a mutation in the repeated sequence "b" and its inverted sequence "bЈ" (30) (at or adjacent to genomic residues 5462 to 5463 and 12904 to 120905, respectively, in strain 17 DNA) ( Table 2). This mutation may affect the gene for R L 2 (residues 2261 to 5489 and residues 120882 to 124110, strain 17, ␣0 or ICP0 protein) and latency-associated transcript (LAT) genes (residues 118802 to 127143) (NCBI gene identification 2828259) (9,31,34,46).…”